Concarlo Holdings

0 followers


Concarlo is a precision-medicine oncology company focused on diagnosing and treating cancer with an innovative approach to targeting a unique cellular pathway - p27Kip1.

Industries

Headquarters

Stage

Employees

Links

Org chart

Stacy Blain
Co-Founder, CSO & CEO

Stacy Blain

Collapse
Jason Mraz
Co-Founder, Seed Investor
Dominique Bridon
Chief Development Officer
Krishna Allamneni
Chief Development Officer
Kate Coleman
Principal Scientist
Natalia Zisman
Director, Chemistry, Manufacturing & Controls